[Cytokine therapy of superficial bladder carcinoma. Mechanisms of action and results of therapy].
The object of immunotherapy is the elimination of tumor cells mediated by modulation of the immune system. This can be achieved by different mechanisms, i.e. cell-mediated and humorally mediated immune reactions. Immunotherapy can be classified as passive, adoptive, active and non-conventional. Most clinical experience has been gathered with unspecific active immunotherapy. Superficial bladder carcinomas can be treated by intravesical application of Bacillus Calmette-Guérin (BCG) or of different cytokines, i.e., interferons or interleukin-2. Since there has not so far been any standard immunotherapy for superficial bladder carcinoma, the efficacy of therapy with cytokines should be evaluated in clinical studies (phase II/III) only.